Skip to main content

Praxis Precision Medicines, Inc.

PRAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689548

No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Praxis Precision Medicines, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of PRAX: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders7460−14
SharesConverted for a 1-for-15 split7.63M8.02M+389.3K (+5.1%)
Value$195.6M$178.6M−$17.0M (−8.7%)

New holders (10)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to PRAX in Q4 2023
InstitutionSharesValue% of portfolio
Wildcat Capital Management, LLC16,756$373.3K0.13%
Man Group plc13,139$292.7K0.00%
683 Capital Management, LLC11,481$255.8K0.03%
Jane Street Group, LLC10,576$235.6K0.00%
DLD Asset Management, LP10,000$222.8K0.04%
Barclays PLC9,245$206.0K0.00%
UBS Group AG2,699$60.1K0.00%
Simplex Trading, LLC1,392$31.0K0.00%
Royal Bank of Canada1,157$26.0K0.00%
FSA Wealth Management LLC21$00.00%

Sold out (24)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.